APA-viite

Aurora, S., Dodick, D., Diener, H., DeGryse, R., Turkel, C., Lipton, R., & Silberstein, S. (2014). OnabotulinumtoxinA for chronic migraine: Efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program. BlackWell Publishing Ltd.

Chicago-tyylinen lähdeviittaus

Aurora, SK, DW Dodick, H-C Diener, RE DeGryse, CC Turkel, RB Lipton, ja SD Silberstein. OnabotulinumtoxinA for Chronic Migraine: Efficacy, Safety, and Tolerability in Patients Who Received All Five Treatment Cycles in the PREEMPT Clinical Program. BlackWell Publishing Ltd, 2014.

MLA-viite

Aurora, SK, et al. OnabotulinumtoxinA for Chronic Migraine: Efficacy, Safety, and Tolerability in Patients Who Received All Five Treatment Cycles in the PREEMPT Clinical Program. BlackWell Publishing Ltd, 2014.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.